Skip to main content
April 2024 Research Awards

April 2024 Research Awards

Investigator Sponsor Type Project Title Begin Date End Date Awarded Dollars
Liana G Apostolova Alzheimer Association New iLEADS-24-1277370 1/1/2024 12/31/2025 $607,823.92
Camila Libel Arnaudo Indiana Family And Social Services Administration Renewal (not prev committed) Perinatal and Adult Psychiatry Access Line 7/1/2023 6/30/2025 $1,709,950.00
Jeff Brault East Carolina University New Mitochondrial bioenergetics and colorectal cancer 2/19/2024 1/31/2025 $21,867.00
Jared Robert Brosch University Of Southern California New AHEAD Plasma Extension (APEX) 12/1/2023 11/30/2024 $53,800.00
Jared Robert Brosch Fordham University New Alzheimer's Disease Neuroimaging Initiative (ADNI4) 12/1/2023 7/31/2024 $85,929.00
Amy Caldwell Health And Hospital Corporation Of Marion County Renewal (not prev committed) Title X Program Family Planning Medical Director 4/1/2023 3/31/2024 $5,623.00
Yelena Chernyak Patient-centered Outcomes Research Institute Renewal (not prev committed) Patient-centered Treatment of Anxiety after Low-Risk Chest Pain in the Emergency Room (PACER) 1/1/2025 12/31/2026 $966,083.00
Mary R. Ciccarelli Riley Children's Foundation Renewal (not prev committed) Haddad Early Autism Evaluation and Biomarker Projects 4/1/2022 3/31/2025 $150,000.00
Jill Diane Connors Patient-centered Outcomes Research Institute Renewal (not prev committed) Patient-centered Treatment of Anxiety after Low-Risk Chest Pain in the Emergency Room (PACER) 1/1/2025 12/31/2026 $966,083.00
Steven Raymond Counsell Massachusetts General Hospital New Annual Wellness Visits vs GRACE-augmented Annual Wellness Visits For Older Adults with High Needs 1/1/2024 12/31/2024 $173,865.00
Laura Cracco National Institute Neurological Disorders & Stroke New Investigating the role of TDP-43 mislocalization, structure, and post-translational modifications in the neuropathologically heterogeneous TDP-43 proteinopathies 4/16/2024 3/31/2025 $1,029,657.00
Kenneth W. Dunn Nih Office Of The Director New Lightsheet microscope system for the Indiana Center for Biological Microscopy 4/1/2024 3/31/2025 $562,000.00
Greg Durm University Of North Carolina At Chapel Hill New A Phase II Trial of Induction and Maintenance Pembrolizumab and Olaparib in Locally Advanced Head and Neck Squamous Cell Carcinoma 4/4/2024 4/3/2029 $54,824.00
Conner Clair Earl National Heart, Lung And Blood Institute New Spatiotemporal and Deep Learning Analysis of Cardiac Imaging for Predictive Risk Stratification in Duchenne Muscular Dystrophy 4/1/2024 8/4/2024 $16,224.00
Jeffrey J Easler University Of Pittsburgh New Integrating Radiomics and Genomics to Improve the Clinical Assessment of Pancreatic Cysts and Early Detection of Pancreatic Cancer 8/1/2023 7/31/2024 $10,050.00
Aaron Christopher Ermel The Carter Center New Ocular Chlamydia Trachomatis Monitoring Project 3/18/2024 3/17/2025 $15,500.00
Kathryn Dee Fischer Applied Research Institute New Pharmacological alterations of the DA system interacts in SB-121-fed BTBR mice during social, cognitive, and locomotor behaviors 4/11/2024 4/10/2025 $49,871.00
Erick Forno University Of Pittsburgh New SCH: Bringing Intelligence to Pulmonology: New AI-Enabled Systems for Pulmonary Function Tests Anytime and Anywhere 10/1/2023 9/30/2026 $130,532.00
Jennifer Hamner International Society For The Study Of Women's Sexual Health New A Prospective Study of the Impact of Levonorgestrel Intrauterine Devices on Sexual and Bladder Dysfunction 7/1/2024 6/30/2025 $7,500.00
Leng Han University Of Texas Md Anderson Cancer Center New Molecular Mechanisms of Bladder Cancer Immunometabolism 6/1/2023 2/28/2025 $112,782.00
Tina M Harris Indiana University Health New Above The Influence Workshop 4/1/2024 3/31/2026 $57,557.00
Yoshikazu Imanishi National Eye Institute New Membrane compartmentalization in photoreceptor health and disease 5/1/2024 4/30/2025 $542,636.00
Seethal A Jacob Rhode Island Hospital New Maximizing Fetal Hemoglobin Responses to Hydroxyurea using Precision Medicine 4/1/2022 12/31/2023 $7,629.00
Danielle Janosevic National Institute Of Diabetes, Digestive & Kidney New Transcriptomic Diagnosis and Staging of Sepsis-Associated Acute Kidney Injury 4/15/2024 1/31/2025 $157,953.00
Adam C Kean Ann & Robert H Lurie Children Hospital Of Chi New Investigating structural and genetic substrates of early-onset atrial fibrillation 7/1/2023 6/30/2028 $5,500.00
Kurt Kroenke Patient-centered Outcomes Research Institute Renewal (not prev committed) Patient-centered Treatment of Anxiety after Low-Risk Chest Pain in the Emergency Room (PACER) 1/1/2025 12/31/2026 $966,083.00
Mark P. Langer Intuitive Foundation New Adjuvant Treatment Deintensification after Transoral Surgery for Human Papillomavirus-Positive Squamous Cell Carcinoma of the Oropharynx 1/1/2024 12/31/2024 $75,000.00
Cristian Alberto Lasagna Reeves National Institute On Aging Renewal (not prev committed) CAA, Tau and Neurodegeneration 5/1/2024 4/30/2027 $2,251,074.00
Karen Theresa Liby U.s. Army Medical Research Acquisition Activity New A novel NRF2 pathway inhibitor for treating lung cancer 9/1/2023 8/31/2025 $511,838.00
Patrick J. Loehrer Eli Lilly And Company Foundation New AMPATH Breast and Cervical Cancer Screening to Improve Women?s Cancer Outcomes in Kenya and Nepal 12/1/2023 11/30/2026 $2,000,000.00
Luke A Lopas Mid-america Orthopaedic Association New Mid-America Orthopaedic Association Annual Meeting 4/1/2024 6/30/2024 $2,500.00
Larry Wayne Markham National Heart, Lung And Blood Institute New Spatiotemporal and Deep Learning Analysis of Cardiac Imaging for Predictive Risk Stratification in Duchenne Muscular Dystrophy 4/1/2024 8/4/2024 $16,224.00
Rebecca McNally Keehn Riley Children's Foundation Renewal (not prev committed) Haddad Early Autism Evaluation and Biomarker Projects 4/1/2022 3/31/2025 $150,000.00
Olha Melnyk Diabetes Research Connection New Evaluation of lysosome dysfunction during autoimmune diabetes pathogenesis 4/5/2024 4/4/2025 $49,499.00
Michael S. Metrick Indiana Family And Social Services Administration Renewal (not prev committed) Perinatal and Adult Psychiatry Access Line 7/1/2023 6/30/2025 $1,709,950.00
Patrick O Monahan Patient-centered Outcomes Research Institute Renewal (not prev committed) Patient-centered Treatment of Anxiety after Low-Risk Chest Pain in the Emergency Room (PACER) 1/1/2025 12/31/2026 $966,083.00
Jenny S Morgan Eli Lilly And Company Foundation New AMPATH Breast and Cervical Cancer Screening to Improve Women's Cancer Outcomes in Kenya and Nepal 12/1/2023 11/30/2026 $2,000,000.00
Paul Musey Patient-centered Outcomes Research Institute Renewal (not prev committed) Patient-centered Treatment of Anxiety after Low-Risk Chest Pain in the Emergency Room (PACER) 1/1/2025 12/31/2026 $966,083.00
Roman M Natoli Johns Hopkins University New PO versus IV Antibiotics for the Treatment of Infected Nonunion of Fractures After Fixation 9/30/2022 9/29/2024 $32,151.00
Kathy L Newell National Institute Neurological Disorders & Stroke New Investigating the role of TDP-43 mislocalization, structure, and post-translational modifications in the neuropathologically heterogeneous TDP-43 proteinopathies 4/16/2024 3/31/2025 $1,029,657.00
Heather M O'Hagan National Cancer Institute New Targeting LSD1 to prevent therapy-induced transdifferentiation in BRAF mutant colorectal cancer 4/1/2024 3/31/2025 $431,920.00
Padmanabhan Pattabiraman National Eye Institute New Transcriptional control of lipid biogenesis in trabecular meshwork and intraocular pressure regulation 5/1/2024 4/30/2025 $486,865.00
Douglas K Rex Indiana University Health New Optical diagnosis versus laser measurement of polyps size during colonoscopy and implications for surveillance 4/18/2024 4/17/2029 $25,803.00
Andrew J Saykin Research!america New IMPACT Indiana Initiative 2024 11/1/2023 5/20/2024 $3,400.00
Michael Wisung Sim Intuitive Foundation New Adjuvant Treatment Deintensification after Transoral Surgery for Human Papillomavirus-Positive Squamous Cell Carcinoma of the Oropharynx 1/1/2024 12/31/2024 $75,000.00
Emily K Sims Pacific Northwest National Laboratory New Robust Mass Spectrometric Protein/Peptide Assays for Type 1 Diabetes Clinical Applications 2/22/2024 6/30/2024 $42,277.00
Anita Ahmed Turk Hoosier Cancer Research Network New Phase 2 Study of Gemcitabine, Cisplatin, Quemliclustat (AB680) and Zimberelimab(AB122) during First-Line Treatment of Advanced Biliary Tract Cancers 3/18/2024 3/17/2029 $114,534.00
Bree Ashley Weaver Health And Hospital Corporation Of Marion County Renewal (not prev committed) Midwest AIDS Training and Education Center (MATEC) Program 7/1/2023 6/30/2024 $13,055.00
Jimmy Yen Alzheimer Association New Impact of systemic interferon responses in Alzheimer's disease 6/1/2024 5/31/2027 $199,820.00
Ivorine Yu Alzheimer Association New Impact of systemic interferon responses in Alzheimer's disease 6/1/2024 5/31/2027 $199,820.00
Default Author Avatar IUSM Logo
Author

IU School of Medicine

With more than 60 academic departments and specialty divisions across nine campuses and strong clinical partnerships with Indiana’s most advanced hospitals and physician networks, Indiana University School of Medicine is continuously advancing its mission to prepare healers and transform health in Indiana and throughout the world.

The views expressed in this content represent the perspective and opinions of the author and may or may not represent the position of Indiana University School of Medicine.